Ad Hoc Committee Update: Impact of NCAA Sickle Cell Trait Mandate Alexis Thompson January 16, 2014.

Slides:

Advertisements

Similar presentations

CDC EHDI RESOURCES for States. CDC EHDI Website CDC EHDI Website Purpose: To provide up-to-date.

Advertisements

DSHS Texas Newborn Screening Program Processes Susan Tanksley, PhD David Martinez April 10, 2008.

Day 2 You receive 2 reports on your desk –The first describes the possibility of expanding the states newborn screening panel to include Severe Combined.

SIM- Data Infrastructure Subcommittee January 8, 2014.

Participation Requirements for a Patient Representative.

CDC Recommendations for HIV Testing of Adults and Adolescents Christina Price, MPH Delta Region AIDS Education and Training Center.

Newborn Screening & Medical Foods Policy Overview Fatty Oxidation Disorders/Organic Acidemia Association Annual Conference July 26, 2014 Melanie Lockhart.

Disability Access Route to Education Schools Presentation.

Decision Criteria and Process Advisory Committee on Heritable Disorders in Newborns and Children February 26-27, 2009.

1 Legal Framework for the Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children (SACHDNC) Legal Framework for the Secretary’s.

California Child Welfare Co-Investment Partnership Children’s Conference Monterey, California May 29, 2008.

Combating Autism Act Initiative State Implementation Grant Maria Nardella Children with Special Health Care Needs Program Manager Washington Department.

Draft manuscript: “Implementing Point-of-Care Newborn Screening” From the SACHDNC Follow-up & Treatment Sub-committee 1/27/2012 Nancy S. Green, MD Associate.

9/16/2010 Secretary's Advisory Committee on Heritable Disorders in Newborns and Children1 NBS Quality Measures for Meaningful Use of EHR Presentation by.

C. difficile Subcommittee Summary HAI Advisory Committee Nov 18, 2010 Submitted by R. Murthy, MD (Subcommittee Chair)

Subject Selection and Recruitment David Wendler Department of Clinical Bioethics NIH, USA.

Use of Children as Research Subjects What information should be provided for an FP7 ethical review?

Ad Hoc Disease Transmission Advisory Committee Spring 2015.

ESEA FLEXIBILITY RENEWAL PROCESS: FREQUENTLY ASKED QUESTIONS January29, 2015.

Evolution of ICCVAM ◊National Toxicology Program Develop and validate improved test methods ◊NIH Revitalization Act: P.L Develop and.

EMGO Institute for Health and Care Research Quality of Care Martina Cornel, MD, PhD, professor of Community Genetics & Public Health Genomics PPPC activities.

History of the Other Work of the SACHDNC Alex R. Kemper, MD, MPH, MS September 22, 2011.

Safeguarding Animal Health 1 Proposed BSE Comprehensive Rule: A New Approach to BSE Rulemaking Dr. Christopher Robinson Assistant Director, NCIE BSE Comprehensive.

1 Meeting with Contacts for TB Assessment. Learning Objectives After this session, participants will be able to: 1.Explain why contact assessments are.

Student Athlete Sports Medicine Clearance Process Tutorial Audio will begin automatically.

Presented DATE to GROUP NAME The Great Lakes Border Health Initiative.

Improving Data Quality and Quality Assurance in Newborn Screening by Including the Bloodspot Screening Collection Device Serial Number on Birth Certificates.

1 May 2007 Instructions for the WG Chair The IEEE-SA strongly recommends that at each WG meeting the chair or a designee: l Show slides #1 through #5 of.

Community Feedback and Involvement in [Health Department’s] Proposed Data to Care Program [Name of Provider Session Date of Provider Session]

The National Vaccine Plan Process - Update October 22, 2007 Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human Services.

Governor’s Taskforce for Pandemic Influenza Preparedness Issue Paper Communications Workgroup Members Robert Rolfs, State Epidemiologist, Utah Department.

HIV Testing In Vermont Update 2007 Cathleen Harris, MD Fletcher Allen Health Care.

Screening Implementation: Referral and Follow-up What Do You Do When the Screening Test Is of Concern? Paul H. Lipkin, MD D-PIP Training Workshop June.

TM Subcommittee on Treatment and Follow up Advisory Committee on Heritable Disorders in Newborns and Children.

Facility-Specific Employee Influenza Vaccination Data for : Options and Considerations for Public Postings Kate Cummings, MPH Healthcare Associated.

Bob Bowman, MS Director of Genomics & Newborn Screening Indiana State Department of Health.

Proposed Changes to Advisory Committee Processes Sara Copeland, MD Designated Federal Official Secretary’s Advisory Committee on Heritable Disorders in.

The California Health Benefit Exchange: Design Options HBEX Board Meeting Tuesday, September 27, 2011.

PSO Overview for Executives (Presenter) (Date) Center for Patient Safety Toolkit for PSO Participation, Section 4.

Christopher N. Greene, PhD Newborn Screening and Molecular Biology Branch, Division of Laboratory Sciences NCEH, CDC Tuesday, 28th June 2011 Molecular.

GOVERNOR’S EARLY CHILDHOOD ADVISORY COUNCIL (ECAC) September 9, 2014.

Department of Health and Human Services Office of the Assistant Secretary for Health (ASH) Advisory Committee on Blood Safety and Availability (ACBSA)

Routine Opt-Out HIV Testing Texas STD Clinics James H. Lee, Senior Public Health Advisor HIV/STD Program Texas Department of State Health Services.

Update on the ACHA National College Health Assessment Using the ACHA-NCHA to Examine the Health Status and Health Needs of Your Students An ACHA Professional.

ACBCYW HIGH RISK Ad Hoc WORKGROUP REPORT March 2014.

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 1 Nursing Diagnoses: Issues and Controversies.

Draft Policy Allocation of IPv4 and IPv6 Address Space to Out-of-region Requestors 59.

Update on SACHDNC Administrative Processes Sara Copeland, MD Chief, Genetics Services Branch Designated Federal Officer Secretary’s Advisory Committee.

Ad Hoc Disease Transmission Advisory Committee Fall 2014.

DEVELOPING PARENT INVOLVEMENT POLICIES Title I No Child Left Behind (NCLB) Section 1118.

I have no relevant financial relationships with the manufacturers of any commercial products and/or provider of commercial services discussed in this CME.

Recommendation Methods Advisory Committee on Heritable Disorders and Genetic Diseases of Newborns and Children Ned Calonge, M.D., M.P.H.

Guidance Training (F520) §483.75(o) Quality Assessment and Assurance.

1 Strategic Plan Review. 2 Process Planning and Evaluation Committee will be discussing 2 directions per meeting. October meeting- Finance and Governance.

The Impact of Obtaining Documented Informed Consent on MS/MS Screening L.A. Faulkner 1, L.B. Feuchtbaum 2, M. Hanlon 1, F.W. Lorey 2, K. Velazquez 2, and.

Ad Hoc Disease Transmission Advisory Committee Fall 2014.

Update: AUL Guidance Revisions Summary of Comments June 23, 2011 Peggy Shaw Workgroup Chair.

Follow-Up and Treatment Subcommittee Proposed Priorities and Projects May 18, 2012 Carol L. Greene, M.D.

National Immunization Program (NIP)/Advisory Committee on Immunization Practices (ACIP) Report Stephen L. Cochi, MD, MPH Acting Director, National Immunization.

HIPAA Privacy Rule Positive Changes Affecting Hospitals’ Implementation of the Rule.

Unit 3 Seminar.  Used to predict acceptable or unacceptable behavior  Helps to assess level of skills/knowledge/ characteristics applicants have  Reduce.

Pulse Oximetry Screening for Critical Congenital Heart Disease (CCHD): The Wisconsin Experience Region IV Genetics Meeting September 11, 2012 Sharon Fleischfresser.

Six Years Later: Tiffany A. Tate, MHS Maryland Partnership for Prevention, Inc. National Immunization Conference March 30, 2011 Lessons Learned from a.

Child and Family Services Reviews Onsite Review Instrument.

HIPAA Privacy Rule Positive Changes Affecting Hospitals’ Implementation of the Rule Melinda Hatton -- Oct. 31, 2002.

Fig Specific Conditions – Newborn Screening for Sickle Cell Disease

Diagnostic testing is genetic testing to diagnose a childhood condition or conditions that can be treated medically during childhood. An example is retinoblastoma.

Disability Rights and the United Nations: Developing Hard Law

Modify HOPE Act Variance to Include Other Organs

Minority Affairs Committee Update

Presentation transcript:

Ad Hoc Committee Update: Impact of NCAA Sickle Cell Trait Mandate Alexis Thompson January 16, 2014

Objectives  Review SACHDNC report on screening of U.S. college athletes for sickle cell trait  Describe the impact of NCAA policy on states  Report work to date of the Ad Hoc Subcommittee  Feedback/Next Steps

 Do the SACHDNC recommendations still stand?  Is this an appropriate use of newborn screening resources?  Can/should the DACHDNC provide additional guidance to the Secretary and/or states?  How does this experience impact the broader discussion of notification of carrier status for other conditions?

Secretary’s Advisory Committee on Heritable Disorders of Newborns and Children (2010)*  Individuals should have the opportunity to find out their risk of medical disorders, including carrier status for sickle cell disease  Evaluation should take place in the medical home and should include counseling and assurances about the privacy of genetic information  Genetic testing should not be a pre-requisite for participation in sports, unless deemed medically necessary  As part of routine medical care, all potential athletes should be given education of safe practices to prevent exercise and heat related illnesses * Recommendations accepted by Secretary Kathleen Sebelius June 27, 2011

SACHDNC Statement (2010)  Reviewed by Ad Hoc Subcommittee  Consensus : Recommendations made in 2010 are still valid  No changes proposed

Information Provided by States  Highly variable  Not clear that any information is given besides actual test result  Some efforts providing additional information rebuffed by universities/athletic department personnel  Need for disclaimer?  Risk of false positive and false negative results  Screening vs diagnostic testing  Issues with accuracy and matching

Is this an appropriate use of NBS?  Burden and Cost  If results provided without contextual information, is this consistent with the intent of newborn screening?  Actions of states driven by public policy, health legislation  If states see this as a reasonable use of NBS, what recommendations are given? To whom?  Data on current practices not available  Resources for information on sickle cell trait?

Educational Resources on Sickle Cell Trait  CDC developing a Sickle Cell Trait Education Toolkit  Workgroups on general information, complications and athletics  Materials vetted through SCDAA and ASH  General FAQs currently in CDC clearance  Plan for other items completed by Spring 2014  Will be available for downloading from CDC website

Summary to date  We believe that the SACHDNC recommendations should still stand  Late request for NBS results solely to address the NCAA mandate is not an appropriate use of newborn screening resources  How can DACHDNC provide additional guidance to the Secretary and/or states? - TBD

Next Steps  Gather additional information from states  Clarification on current guidelines for carrier notification  Ascertain what (if any) disclaimer about the results is given  Determine educational information is provided (if at all) with results  Articulate the concerns raised by the NCAA mandate  Draft report  Consider mechanisms by which SACHDNC can offer assistance to states